Related Articles
Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia
Polyamine analog TBP inhibits proliferation of human K562 chronic myelogenous leukemia cells by induced apoptosis
Dual PI3K/mTOR inhibitor NVP‑BEZ235 decreases the proliferation of doxorubicin‑resistant K562 cells
Knockdown of HOXA10 reverses the multidrug resistance of human chronic mylogenous leukemia K562/ADM cells by downregulating P-gp and MRP-1 Corrigendum in /10.3892/ijmm.2023.5315
Idelalisib induces G1 arrest and apoptosis in chronic myeloid leukemia K562 cells